Copper complexes as candidate therapeutic agents against infiltrative glioblastoma cells
values below 10 μM in 2D cultures and below 20 μM in 3D spheroids. Treatment with the complexes led to a marked increase in reactive oxygen species, suggesting oxidative stress as a key component of their mechanism. However, caspase-3/7 activation remained minimal, indicating that cell metabolic impairment was not significantly associated with caspase-3/7-mediated apoptosis. This study demonstrates that Schiff base copper(ii) complexes hold meaningful therapeutic potential against a disease for which current outcomes remain devastating.
Authors
- Luisa Ciano (ORCID: https://orcid.org/0000-0002-1667-0856)
- Phoebe McCrorie (ORCID: https://orcid.org/0000-0001-6892-497X)
- Cara Moloney (ORCID: https://orcid.org/0000-0002-2230-6612)
- Ruman Rahman (ORCID: https://orcid.org/0000-0002-6541-9983)
- Une Kontrimaite (ORCID: https://orcid.org/0000-0003-3750-2605)
- Stephen Argent (ORCID: https://orcid.org/0000-0002-3461-9675)
- Kayley Mulhall
- Konstantinos-Panagiotis Karadimas
- Thomas Weston
- Dylan Smith
- Harry Porter
- Sophie Melling
Institutions
- University of Nottingham (GB)
Publication Details
- Journal
- RSC Medicinal Chemistry
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1039/d6md00801a
- Primary Topic
- Metal complexes synthesis and properties
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Nottingham
- Brain Tumour Research